A more practical way to think about semaglutide and liver risk MASH usually sits inside a broader metabolic picture that includes weight, insulin resistance, and inflammatory strain on the liver. Semaglutide may become…
Read More
A clearer next step when oral GLP-1 options start to sound real Two oral GLP-1 medicines—Wegovy tablets (semaglutide) and Foundayo (orforglipron)—are now FDA-approved for chronic weight management in eligible adults. The better question…
Read More